20160128 EGA Regulatory and Scientific Affairs Conferenc

European Parliament report calls for increased use of off-patent medicines to improve patient access

24 November 2021

Read More

The EU must stop the offshoring of essential medicines manufacturing investments

23 November 2021

Read More

Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021


Adjustments to IP framework needed to improve access to medicines in Europe

16 November 2021

Access to generic and biosimilar medicines can be improved with coherent proposals for IP […]

Read more

Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021


Access to medicines critical in European Parliament vote on EU IP action plan

12 November 2021

The European Parliament Own Initiative Report on an intellectual property […]

Read more

European Commission pilot project on repurposing brings value added innovation to life

28 October 2021

Innovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today […]

Read more

Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

Read more

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]

Read more

Smart use of off-patent medicines will be critical to rebuild healthcare systems successfully post-Covid

7 October 2021

Read More

Subscribe to our newsletter